The European Commission has entered into an agreement with AstraZeneca under which it will purchase 300 million coronavirus vaccines from the company for EU countries and EU partners in other parts of the world. Poland has also joined the agreement. Some vaccines are to be donated to lower and middle-income countries.
The coronavirus vaccine from AstraZeneca is in testing
The European Commission announced on Friday (August 14) that it had concluded an agreement with the pharmaceutical company Astra Zeneca to purchase 300 million doses of the vaccine against COVID-19. This is yet another pharmaceutical concern with which the European Commission conducted such talks. The positive results of talks with Sanofi-GFK were announced by the European Commission on July 31, and on August 13 a similar communiqué about the negotiations with Johnson & Johnson appeared. All these agreements provide for the possibility of the European Commission purchasing millions of doses of the vaccine for the needs of EU countries, EU partner countries and the poorest countries (to whom they are to be donated). The agreement with AstraZeneca was concluded after the safety and efficacy of the vaccine had been demonstrated, which, however, is still in clinical trials. On behalf of the EU countries, the commission agreed on the basis of a framework contract for the purchase of 300 million doses of the vaccine with the option of purchasing a further 100 million doses. As indicated by money.pl, Poland joined the agreement to purchase vaccines for the community a few days ago.